A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis

OBJECTIVES: Therapies for treatment of patients with primary sclerosing cholangitis (PSC) include administration of ursodeoxycholic acid (UDCA) alone, or combination with metronidazole (MTZ) or mycophenolate mofetil (MMF), respectively. However, the optimum regimen still remains inconclusive. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Gui-Qi, Shi, Ke-Qing, Huang, Gui-Qian, Wang, Li-Ren, Lin, Yi-Qian, Braddock, Martin, Chen, Yong-Ping, Zhou, Meng-Tao, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper: Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694950/
https://www.ncbi.nlm.nih.gov/pubmed/26378046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694950/
https://www.ncbi.nlm.nih.gov/pubmed/26378046

Ejemplares similares